Gelcompany's HPE System Makes Debut into US with Adoption by Yale Researcher | GenomeWeb

This story originally published on May 6.

Australian fluorescence firm, Gelcompany this week said that Yale University has adopted its High Performance Electrophoresis FlatTop Tower system, as take-up of the instrument ramps up.

Terence Wu, director of Yale University's W.M. Keck Foundation Biotechnology Resource Laboratory will be using the instrument for his electrophoresis workflow, Gelcompany said in a statement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.